| scholarly article | Q13442814 |
| P50 | author | In-Hyun Park | Q90576463 |
| P2093 | author name string | Leeyup Chung | |
| Kun-Yong Kim | |||
| Gareth J Sullivan | |||
| Yong Wook Jung | |||
| P2860 | cites work | Functional and anatomical cortical underconnectivity in autism: evidence from an FMRI study of an executive function task and corpus callosum morphometry | Q22242905 |
| Advances in autism genetics: on the threshold of a new neurobiology | Q22251023 | ||
| Genetics of austim: complex aetiology for a heterogeneous disorder | Q22251288 | ||
| Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism | Q24299042 | ||
| Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism | Q24307957 | ||
| Mutations in the ribosomal protein gene RPL10 suggest a novel modulating disease mechanism for autism | Q48434105 | ||
| Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice | Q48569575 | ||
| Prevalence of parent-reported diagnosis of autism spectrum disorder among children in the US, 2007. | Q50306443 | ||
| A prevalence study of pervasive developmental disorders in North Dakota | Q50308209 | ||
| Translational suppression by trinucleotide repeat expansion at FMR1. | Q52016323 | ||
| DNA methylation represses FMR-1 transcription in fragile X syndrome | Q52042005 | ||
| Neuropathology of Rett syndrome | Q81353275 | ||
| Recurrent copy number variations in human induced pluripotent stem cells | Q84306754 | ||
| Targeting DNA double-strand breaks with TAL effector nucleases | Q24605087 | ||
| Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells | Q24616059 | ||
| Enhanced polyubiquitination of Shank3 and NMDA receptor in a mouse model of autism | Q24620573 | ||
| Modelling schizophrenia using human induced pluripotent stem cells | Q24633007 | ||
| Direct conversion of fibroblasts to functional neurons by defined factors | Q24641912 | ||
| Disease-specific induced pluripotent stem cells | Q24641981 | ||
| Virus-free induction of pluripotency and subsequent excision of reprogramming factors | Q24644686 | ||
| Autism spectrum disorders and childhood-onset schizophrenia: clinical and biological contributions to a relation revisited | Q24647915 | ||
| Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins | Q24653753 | ||
| Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells | Q26269888 | ||
| Induction of human neuronal cells by defined transcription factors | Q26269896 | ||
| Capture of neuroepithelial-like stem cells from pluripotent stem cells provides a versatile system for in vitro production of human neurons | Q27310383 | ||
| Mapping autism risk loci using genetic linkage and chromosomal rearrangements | Q27315912 | ||
| Establishment in culture of pluripotential cells from mouse embryos | Q27860625 | ||
| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies | Q28190066 | ||
| Enhancing Gene Targeting with Designed Zinc Finger Nucleases | Q28202461 | ||
| Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury | Q28250167 | ||
| Evolution of the neocortex: a perspective from developmental biology | Q28258984 | ||
| A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden | Q28277400 | ||
| A TALE nuclease architecture for efficient genome editing | Q28301656 | ||
| Autism as a strongly genetic disorder: evidence from a British twin study | Q28303915 | ||
| Isogenic pairs of wild type and mutant induced pluripotent stem cell (iPSC) lines from Rett syndrome patients as in vitro disease model | Q28477225 | ||
| Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors | Q28749672 | ||
| Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery | Q29014419 | ||
| Epigenetic memory in induced pluripotent stem cells | Q29547892 | ||
| Induced pluripotent stem cells from a spinal muscular atrophy patient | Q29614340 | ||
| Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes | Q29614341 | ||
| Transcriptomic analysis of autistic brain reveals convergent molecular pathology | Q29614877 | ||
| Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling | Q29615601 | ||
| A copy number variation morbidity map of developmental delay | Q29616033 | ||
| Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice | Q29616328 | ||
| Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency | Q29616797 | ||
| Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits | Q29618411 | ||
| Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells | Q29619469 | ||
| Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease | Q29619506 | ||
| Chromosomal translocations induced at specified loci in human stem cells. | Q37238361 | ||
| Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases | Q37239088 | ||
| Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in parkinsonian rats | Q37255180 | ||
| Copy number variation and association analysis of SHANK3 as a candidate gene for autism in the IMGSAC collection | Q37363898 | ||
| A genome-wide linkage and association scan reveals novel loci for autism | Q37410600 | ||
| Coordination of sonic hedgehog and Wnt signaling determines ventral and dorsal telencephalic neuron types from human embryonic stem cells | Q37424536 | ||
| The conundrums of understanding genetic risks for autism spectrum disorders | Q37613535 | ||
| Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation | Q37734466 | ||
| Key role for gene dosage and synaptic homeostasis in autism spectrum disorders | Q37770646 | ||
| Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming | Q39879443 | ||
| Generation of induced pluripotent stem cells from human cord blood. | Q39942465 | ||
| Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos | Q39997723 | ||
| Sequencing and analyzing the t(1;7) reciprocal translocation breakpoints associated with a case of childhood-onset schizophrenia/autistic disorder | Q40172707 | ||
| Transplantation of human embryonic stem cell-derived photoreceptors restores some visual function in Crx-deficient mice | Q41927703 | ||
| Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency | Q42811272 | ||
| Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations. | Q42814127 | ||
| Karotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells | Q45047169 | ||
| Rescue of ataxia and preplate splitting by ectopic expression of Reelin in reeler mice | Q45713976 | ||
| Unexpected X chromosome skewing during culture and reprogramming of human somatic cells can be alleviated by exogenous telomerase | Q46865419 | ||
| Development of patient-specific neurons in schizophrenia using induced pluripotent stem cells | Q47788549 | ||
| Genetic engineering of human pluripotent cells using TALE nucleases | Q29619830 | ||
| A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells | Q29619964 | ||
| Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts | Q29620480 | ||
| Wild-type microglia arrest pathology in a mouse model of Rett syndrome | Q30424614 | ||
| Annual Research Review: Transgenic mouse models of childhood-onset psychiatric disorders | Q30469044 | ||
| Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. | Q30489278 | ||
| Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome | Q30499663 | ||
| Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome | Q30529349 | ||
| Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses | Q30562410 | ||
| Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency | Q33732735 | ||
| Diagnosis and management of autism in childhood | Q34054956 | ||
| Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome | Q34056154 | ||
| Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes | Q34078669 | ||
| Female human iPSCs retain an inactive X chromosome | Q34111572 | ||
| Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader–Willi syndromes | Q34140440 | ||
| A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity. | Q34205743 | ||
| Direct reprogramming of fibroblasts into neural stem cells by defined factors | Q34263432 | ||
| Direct conversion of fibroblasts into stably expandable neural stem cells | Q34263438 | ||
| Induced Pluripotent Stem Cells Can Be Used to Model the Genomic Imprinting Disorder Prader-Willi Syndrome | Q34401155 | ||
| A novel frameshift mutation in UPF3B identified in brothers affected with childhood onset schizophrenia and autism spectrum disorders. | Q34507615 | ||
| Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals | Q34599790 | ||
| Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines | Q34714112 | ||
| Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation | Q34955419 | ||
| Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease | Q35015732 | ||
| Deriving excitatory neurons of the neocortex from pluripotent stem cells | Q35071732 | ||
| Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology | Q35099241 | ||
| Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome | Q35180703 | ||
| iPS cells to model CDKL5-related disorders. | Q35555588 | ||
| Derivation of new human embryonic stem cell lines reveals rapid epigenetic progression in vitro that can be prevented by chemical modification of chromatin | Q35688613 | ||
| Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells | Q35966957 | ||
| Rett syndrome induced pluripotent stem cell-derived neurons reveal novel neurophysiological alterations. | Q36417908 | ||
| Erosion of dosage compensation impacts human iPSC disease modeling | Q36703082 | ||
| Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts | Q36861712 | ||
| Advances in behavioral genetics: mouse models of autism | Q36937876 | ||
| Generation of induced pluripotent stem cells from human blood | Q37209041 | ||
| P433 | issue | 8 | |
| P921 | main subject | autism spectrum disorder | Q1436063 |
| autism | Q38404 | ||
| P304 | page(s) | 463-471 | |
| P577 | publication date | 2012-07-06 | |
| P1433 | published in | Trends in Molecular Medicine | Q15265842 |
| P1476 | title | Cellular reprogramming: a novel tool for investigating autism spectrum disorders | |
| P478 | volume | 18 |
| Q26770097 | A Dishful of a Troubled Mind: Induced Pluripotent Stem Cells in Psychiatric Research |
| Q38161847 | A blueprint for research on Shankopathies: a view from research on autism spectrum disorder |
| Q54983701 | Convergent Pathways in Idiopathic Autism Revealed by Time Course Transcriptomic Analysis of Patient-Derived Neurons. |
| Q38184422 | Great expectations: autism spectrum disorder and induced pluripotent stem cell technologies |
| Q35691087 | MicroRNA Profiling of Neurons Generated Using Induced Pluripotent Stem Cells Derived from Patients with Schizophrenia and Schizoaffective Disorder, and 22q11.2 Del. |
| Q26864380 | Modelling human disease with pluripotent stem cells |
| Q37414577 | Rapamycin regulates autophagy and cell adhesion in induced pluripotent stem cells. |
| Q38162501 | The need for a comprehensive molecular characterization of autism spectrum disorders |
| Q35009147 | Transcriptome comparison of human neurons generated using induced pluripotent stem cells derived from dental pulp and skin fibroblasts |
| Q26827249 | iPSC-derived neurons as a higher-throughput readout for autism: promises and pitfalls |
Search more.